These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37882861)

  • 1. Using race as a social construct when looking at differences in racial associations between non‑alcoholic fatty liver disease and type 2 diabetes. Reply to Rollin FG, Washington C, Fluker S-A [letter].
    Hatano Y; VanWagner LB; Carnethon MR; Bancks MP; Carson AP; Lloyd-Jones DM; Østbye T; Viera AJ; Yano Y
    Diabetologia; 2024 Jan; 67(1):213-214. PubMed ID: 37882861
    [No Abstract]   [Full Text] [Related]  

  • 2. Using race as a social construct when looking at differences in racial associations between non-alcoholic fatty liver disease and type 2 diabetes.
    Rollin FG; Washington C; Fluker SA
    Diabetologia; 2024 Jan; 67(1):211-212. PubMed ID: 37676480
    [No Abstract]   [Full Text] [Related]  

  • 3. Racial and Ethnic Disparities in Nonalcoholic Fatty Liver Disease Prevalence, Severity, and Outcomes in the United States: A Systematic Review and Meta-analysis.
    Rich NE; Oji S; Mufti AR; Browning JD; Parikh ND; Odewole M; Mayo H; Singal AG
    Clin Gastroenterol Hepatol; 2018 Feb; 16(2):198-210.e2. PubMed ID: 28970148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twenty-five-year trajectories of insulin resistance and pancreatic β-cell response and diabetes risk in nonalcoholic fatty liver disease.
    VanWagner LB; Ning H; Allen NB; Siddique J; Carson AP; Bancks MP; Lewis CE; Carr JJ; Speliotes E; Terrault NA; Rinella ME; Vos MB; Lloyd-Jones DM
    Liver Int; 2018 Nov; 38(11):2069-2081. PubMed ID: 29608255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between the lean nonalcoholic fatty liver disease and risk of incident type 2 diabetes in a healthy population of Northwest China: a retrospective cohort study with a 2-year follow-up period.
    Li N; Xang W; Wu S; Li D; Chang M; Xie C; Zhang MY; Tan H
    Front Endocrinol (Lausanne); 2023; 14():1173757. PubMed ID: 37435491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of nonalcoholic steatohepatitis and significant fibrosis in non-obese nonalcoholic fatty liver disease.
    Kim D; Kim W; Joo SK; Kim JH; Harrison SA; Younossi ZM; Ahmed A
    Liver Int; 2019 Feb; 39(2):332-341. PubMed ID: 30298568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the relationships of alcoholic and nonalcoholic fatty liver with hypertension, diabetes mellitus, and dyslipidemia.
    Toshikuni N; Fukumura A; Hayashi N; Nomura T; Tsuchishima M; Arisawa T; Tsutsumi M
    J Clin Biochem Nutr; 2013 Jan; 52(1):82-8. PubMed ID: 23341703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum 25-hydroxyvitamin-D and nonalcoholic fatty liver disease: Does race/ethnicity matter? Findings from the MESA cohort.
    El Khoudary SR; Samargandy S; Zeb I; Foster T; de Boer IH; Li D; Budoff MJ
    Nutr Metab Cardiovasc Dis; 2020 Jan; 30(1):114-122. PubMed ID: 31761548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial differences in prevalence and severity of non-alcoholic fatty liver disease.
    Bonacini M; Kassamali F; Kari S; Lopez Barrera N; Kohla M
    World J Hepatol; 2021 Jul; 13(7):763-773. PubMed ID: 34367497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonalcoholic Fatty Liver Disease and Abdominal Fat Accumulation According to Vitamin D Status in Patients with Type 2 Diabetes.
    Choi DH; Jung CH; Mok JO; Kim CH; Kang SK; Kim BY
    J Obes Metab Syndr; 2018 Mar; 27(1):53-60. PubMed ID: 31089541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of glucagon-to-insulin ratio and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus.
    Moh Moh MA; Jung CH; Lee B; Choi D; Kim BY; Kim CH; Kang SK; Mok JO
    Diab Vasc Dis Res; 2019 Mar; 16(2):186-195. PubMed ID: 30428692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial differences in nonalcoholic fatty liver disease in the U.S. population.
    Schneider AL; Lazo M; Selvin E; Clark JM
    Obesity (Silver Spring); 2014 Jan; 22(1):292-9. PubMed ID: 23512725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial difference in the association between non-alcoholic fatty liver disease and incident type 2 diabetes: findings from the CARDIA study.
    Hatano Y; VanWagner LB; Carnethon MR; Bancks MP; Carson AP; Lloyd-Jones DM; Østbye T; Viera AJ; Yano Y
    Diabetologia; 2023 Jul; 66(7):1235-1246. PubMed ID: 36941389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reply-Letter to the Editor: Critical appraisal for low-carbohydrate diet in nonalcoholic fatty liver disease.
    Kim M; Jun DW
    Clin Nutr; 2020 Jan; 39(1):306. PubMed ID: 31812470
    [No Abstract]   [Full Text] [Related]  

  • 15. Reply to the Letter to the Editor "Adropin: Connection between Nonalcoholic Fatty Liver Disease and Coronary Artery Disease".
    Kutlu O; Altun Ö; Dikker O; Aktaş Ş; Özsoy N; Arman Y; Özgün Çil E; Özcan M; Aydın Yoldemir Ş; Akarsu M; Toprak İD; Kırna K; Kutlu Y; Toprak Z; Eruzun H; Tükek T
    Med Princ Pract; 2020; 29(1):98. PubMed ID: 31505512
    [No Abstract]   [Full Text] [Related]  

  • 16. Histopathological differences utilizing the nonalcoholic fatty liver disease activity score criteria in diabetic (type 2 diabetes mellitus) and non-diabetic patients with nonalcoholic fatty liver disease.
    Puchakayala BK; Verma S; Kanwar P; Hart J; Sanivarapu RR; Mohanty SR
    World J Hepatol; 2015 Nov; 7(25):2610-8. PubMed ID: 26557954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reply to the Letter to the Editor Entitled: "The Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases".
    Turan Y
    Angiology; 2020 Jan; 71(1):88. PubMed ID: 31597437
    [No Abstract]   [Full Text] [Related]  

  • 18. Reply-letter to the editor: Copper deficiency and nonalcoholic fatty liver disease: The chicken or the egg?
    Lan Y; Wang L
    Clin Nutr; 2021 Nov; 40(11):5445-5446. PubMed ID: 34653824
    [No Abstract]   [Full Text] [Related]  

  • 19. Pathologic Diagnosis of Nonalcoholic Fatty Liver Disease.
    Lai J; Wang HL; Zhang X; Wang H; Liu X
    Arch Pathol Lab Med; 2022 Aug; 146(8):940-946. PubMed ID: 34871361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letter: Mendelian randomisation to investigate moderate alcohol consumption in nonalcoholic fatty liver disease; modest effects need large numbers-authors' reply.
    Sookoian S; Pirola CJ
    Aliment Pharmacol Ther; 2017 Aug; 46(4):469-470. PubMed ID: 28707786
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.